ARRY-403
ARRY-403 is a novel glucokinase activator that reduces fasting and postprandial blood glucose in patients with type 2 diabetes.
Product Specifications
CAS Number
1138669-65-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
454.52
Molecular Formula
C20H18N6O3S2
Notes
Research use only, not for human use.
Receptor
Glucokinase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog